Cargando…
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients
Sunitinib is a broad-spectrum multitargeted tyrosine kinase inhibitor mainly used as second-line therapy for non-resectable gastrointestinal stromal or first-line treatment option of metastatic renal cell carcinoma (mRCC), and as an “off-label” option in pediatric oncology. It has been previously re...
Autores principales: | Rihacek, Michal, Selingerova, Iveta, Kocak, Ivo, Kocakova, Ilona, Rihackova, Eva, Valik, Dalibor, Sterba, Jaroslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221843/ https://www.ncbi.nlm.nih.gov/pubmed/35735439 http://dx.doi.org/10.3390/curroncol29060330 |
Ejemplares similares
-
Association of metallothionein 2A rs10636 with low mean corpuscular volume (MCV), low mean corpuscular haemoglobin (MCH) in healthy Taiwanese
por: Chen, Rong-Fu, et al.
Publicado: (2023) -
Relationship of Mean Platelet Volume (MPV) and Mean Corpuscular Volume (MCV) with the Outcome of Patients with Acute Exacerbation of COPD
por: Ziaei, Maryam, et al.
Publicado: (2023) -
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future
por: Rihackova, Eva, et al.
Publicado: (2023) -
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
por: Rihacek, Michal, et al.
Publicado: (2015) -
Interactive Effects between Chronic Lead Exposure and the Homeostatic Iron Regulator Transport HFE Polymorphism on the Human Red Blood Cell Mean Corpuscular Volume (MCV)
por: Chen, Chien-Juan, et al.
Publicado: (2019)